Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isosorbide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107011354B reveals a high-purity AgNO3/SOCl2 nitration route for 5-ISMN, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110590799B reveals a novel melt-acetylation route for isosorbide dinitrate isomers, offering high-purity pharmaceutical intermediates with reduced environmental impact.
Novel activated carbon purification method reduces energy costs and simplifies scale-up for isosorbide mononitrate manufacturing.
Patent CN103641840A details a novel purification method for 5-isosorbide mononitrate, offering high purity and simplified processing for reliable pharmaceutical intermediates suppliers.
Patent CN109776557A reveals a mild dehydration process for isosorbide. Achieve high purity and yield with reduced energy consumption for pharmaceutical intermediates.
Patent CN110407846A reveals high-purity 5-ISMN synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN111253413A details a green Nb2O5 catalytic route for isosorbide. Achieve >85% yield with reduced waste. Ideal for pharma and polymer intermediates.
Patent CN109134485B reveals a high-yield isosorbide synthesis using 1,4-sorbitan and solid acids. Discover cost-effective, scalable bio-based manufacturing solutions.
Patent CN110407846B reveals a novel TMSCl-mediated nitration route for 5-ISMN. Achieve >99% purity and simplified supply chains for cardiovascular intermediates.
Patent CN110407846B introduces a mild, high-selectivity nitration method for 5-ISMN. Discover cost-effective, scalable pharma intermediate manufacturing solutions.
Patent CN104892623B enables high-purity 5-ISMN production. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier solutions.
Advanced nitration process for 5-ISMN ensuring high purity and industrial scalability for pharmaceutical supply chains. This patent data reveals significant cost reduction in API intermediate manufacturing through simplified purification steps and enhanced safety protocols.
Patent CN104892623A reveals high-purity Isosorbide 5-mononitrate synthesis. Enhanced selectivity and cost reduction in pharmaceutical intermediates manufacturing.